Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Auxotrophic mutant of Staphylococcus aureus interferes with nasal colonization by the wild type.

Barbagelata MS, Alvarez L, Gordiola M, Tuchscherr L, von Eiff C, Becker K, Sordelli D, Buzzola F.

Microbes Infect. 2011 Nov;13(12-13):1081-90. doi: 10.1016/j.micinf.2011.06.010. Epub 2011 Jul 13.

PMID:
21784166
3.

Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections.

Weidenmaier C, Kokai-Kun JF, Kristian SA, Chanturiya T, Kalbacher H, Gross M, Nicholson G, Neumeister B, Mond JJ, Peschel A.

Nat Med. 2004 Mar;10(3):243-5. Epub 2004 Feb 1.

PMID:
14758355
4.

Development and characterization of a Staphylococcus aureus nasal colonization model in mice.

Kiser KB, Cantey-Kiser JM, Lee JC.

Infect Immun. 1999 Oct;67(10):5001-6.

5.

Simultaneous lack of catalase and beta-toxin in Staphylococcus aureus leads to increased intracellular survival in macrophages and epithelial cells and to attenuated virulence in murine and ovine models.

Martínez-Pulgarín S, Domínguez-Bernal G, Orden JA, de la Fuente R.

Microbiology. 2009 May;155(Pt 5):1505-15. doi: 10.1099/mic.0.025544-0. Epub 2009 Apr 21.

PMID:
19383704
6.

Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells.

Corrigan RM, Miajlovic H, Foster TJ.

BMC Microbiol. 2009 Jan 30;9:22. doi: 10.1186/1471-2180-9-22.

7.

Nasal carriers are more likely to acquire exogenous Staphylococcus aureus strains than non-carriers.

Ghasemzadeh-Moghaddam H, Neela V, van Wamel W, Hamat RA, Shamsudin MN, Hussin NS, Aziz MN, Haspani MS, Johar A, Thevarajah S, Vos M, van Belkum A.

Clin Microbiol Infect. 2015 Nov;21(11):998.e1-7. doi: 10.1016/j.cmi.2015.07.006. Epub 2015 Jul 13.

9.

Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.

Schaffer AC, Solinga RM, Cocchiaro J, Portoles M, Kiser KB, Risley A, Randall SM, Valtulina V, Speziale P, Walsh E, Foster T, Lee JC.

Infect Immun. 2006 Apr;74(4):2145-53.

10.

Wall Teichoic Acid Glycosylation Governs Staphylococcus aureus Nasal Colonization.

Winstel V, Kühner P, Salomon F, Larsen J, Skov R, Hoffmann W, Peschel A, Weidenmaier C.

MBio. 2015 Jun 30;6(4):e00632. doi: 10.1128/mBio.00632-15.

11.

Evolutionary analyses of Staphylococcus aureus identify genetic relationships between nasal carriage and clinical isolates.

Lamers RP, Stinnett JW, Muthukrishnan G, Parkinson CL, Cole AM.

PLoS One. 2011 Jan 21;6(1):e16426. doi: 10.1371/journal.pone.0016426.

12.

Genome sequencing and analysis reveals possible determinants of Staphylococcus aureus nasal carriage.

Sivaraman K, Venkataraman N, Tsai J, Dewell S, Cole AM.

BMC Genomics. 2008 Sep 22;9:433. doi: 10.1186/1471-2164-9-433.

13.

Staphylococcus aureus Colonization of the Mouse Gastrointestinal Tract Is Modulated by Wall Teichoic Acid, Capsule, and Surface Proteins.

Misawa Y, Kelley KA, Wang X, Wang L, Park WB, Birtel J, Saslowsky D, Lee JC.

PLoS Pathog. 2015 Jul 22;11(7):e1005061. doi: 10.1371/journal.ppat.1005061. eCollection 2015 Jul.

14.

Development of an in vitro colonization model to investigate Staphylococcus aureus interactions with airway epithelia.

Kiedrowski MR, Paharik AE, Ackermann LW, Shelton AU, Singh SB, Starner TD, Horswill AR.

Cell Microbiol. 2016 May;18(5):720-32. doi: 10.1111/cmi.12543. Epub 2016 Jan 12.

15.

Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus--and their relation to community-associated disease activity.

Pan ES, Diep BA, Charlebois ED, Auerswald C, Carleton HA, Sensabaugh GF, Perdreau-Remington F.

J Infect Dis. 2005 Sep 1;192(5):811-8. Epub 2005 Aug 2.

PMID:
16088830
16.

Aromatic Compound-Dependent Staphylococcus aureus Is Safe in a Nasal Colonization Leukopenic Murine Model.

Barbagelata MS, Alvarez LP, Dotto CM, Lattar SM, Sordelli DO, Buzzola FR.

Int J Microbiol. 2012;2012:468539. doi: 10.1155/2012/468539. Epub 2012 Aug 5.

17.

Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection.

O'Callaghan RJ, Callegan MC, Moreau JM, Green LC, Foster TJ, Hartford OM, Engel LS, Hill JM.

Infect Immun. 1997 May;65(5):1571-8.

18.

Virulence of a hemB mutant displaying the phenotype of a Staphylococcus aureus small colony variant in a murine model of septic arthritis.

Jonsson IM, von Eiff C, Proctor RA, Peters G, Rydén C, Tarkowski A.

Microb Pathog. 2003 Feb;34(2):73-9.

PMID:
12623275
19.

Characterization of a serine/threonine kinase involved in virulence of Staphylococcus aureus.

Débarbouillé M, Dramsi S, Dussurget O, Nahori MA, Vaganay E, Jouvion G, Cozzone A, Msadek T, Duclos B.

J Bacteriol. 2009 Jul;191(13):4070-81. doi: 10.1128/JB.01813-08. Epub 2009 Apr 24.

20.

Herpes simplex virus type 1 infection facilitates invasion of Staphylococcus aureus into the nasal mucosa and nasal polyp tissue.

Wang X, Zhang N, Glorieux S, Holtappels G, Vaneechoutte M, Krysko O, Zhang L, Han D, Nauwynck HJ, Bachert C.

PLoS One. 2012;7(6):e39875. doi: 10.1371/journal.pone.0039875. Epub 2012 Jun 29.

Supplemental Content

Support Center